Literature DB >> 2819773

Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis.

R E Strecker, T Sharp, P Brundin, T Zetterström, U Ungerstedt, A Björklund.   

Abstract

The autoregulation of dopamine release and metabolism by intrastriatal grafts of mesencephalic dopamine neurons was examined in vivo using an intracerebral dialysis technique. Dopamine-rich cell suspension grafts were implanted into the head of the caudate putamen in rats with complete unilateral 6-hydroxydopamine lesion of the nigrostriatal dopamine pathway. Six months later behavioural tests indicated that the grafts had reversed the lesion-induced rotational behaviour. Extracellular levels of striatal dopamine and its metabolites 3,4-dihydroxyphenylacetic acid and homovanillic acid were monitored bilaterally in the halothane-anaesthetized grafted rat, both under basal conditions, and also following low (0.05 mg/kg) and high (0.5 mg/kg) doses of the dopamine receptor agonist apomorphine. The perfusate from the grafted striatum showed levels of dopamine which were not statistically different from those of the intact contralateral striatum, indicating that the baseline release of dopamine from the graft was close to normal. Similarly, 3-4-dihydroxyphenylacetic acid and homovanillic acid levels were well recovered on the grafted side (67% and 52%, respectively, of control values). Consistent with previous observations, levels of the serotonin metabolite 5-hydroxyindoleacetic acid measured in perfusate collected from the grafted side was elevated significantly above normal. Subsequent histological analysis revealed large grafts, rich in dopamine-containing neurons (mean +/- SEM number equalled 3138 +/- 630), giving rise to an approximately normal density of dopamine-containing fibres in the area of the host caudate putamen surrounding the probe. Treatment with 0.05 mg/kg (subcutaneous) apomorphine did not affect extracellular dopamine recovered from the grafted striatum, while extracellular DA decreased by a maximum of 30% on the intact side. However, a subsequent injection of 0.5 mg/kg apomorphine produced a large decrease of the dopamine recovered from both the grafted (maximum 40% decrease) and intact striata (maximum 80% decrease). Both the low and the high dose of apomorphine reduced extracellular dopamine metabolite levels, a response which was essentially similar for both the intact and grafted sides. Finally, the dopamine reuptake blocker nomifensine (10(-5) M) added to the perfusion medium produced similar large increases in dopamine in perfusates collected from both grafted and intact striata, while 3,4-dihydroxyphenylacetic acid and homovanillic acid did not change.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2819773     DOI: 10.1016/0306-4522(87)90207-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  28 in total

Review 1.  Transplantation into the human brain: present status and future possibilities.

Authors:  O Lindvall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 2.  Transplantation of embryonic dopamine neurons: what we know from rats.

Authors:  S B Dunnett
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

3.  Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease.

Authors:  Jose A Rodríguez-Gómez; Jian-Qiang Lu; Iván Velasco; Seth Rivera; Sami S Zoghbi; Jeih-San Liow; John L Musachio; Frederick T Chin; Hiroshi Toyama; Jurgen Seidel; Michael V Green; Panayotis K Thanos; Masanori Ichise; Victor W Pike; Robert B Innis; Ron D G McKay
Journal:  Stem Cells       Date:  2006-12-14       Impact factor: 6.277

Review 4.  Transplantation strategies for the analysis of brain development and repair.

Authors:  M Cunningham; R McKay
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

5.  Amelioration of the behavioral phenotype in weaver mutant mice through bilateral intrastriatal grafting of fetal dopamine cells.

Authors:  L C Triarhou; J Norton; J N Hingtgen
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

Review 6.  Emerging regenerative medicine and tissue engineering strategies for Parkinson's disease.

Authors:  James P Harris; Justin C Burrell; Laura A Struzyna; H Isaac Chen; Mijail D Serruya; John A Wolf; John E Duda; D Kacy Cullen
Journal:  NPJ Parkinsons Dis       Date:  2020-01-08

7.  Degeneration and graft-induced restoration of dopamine innervation in the weaver mouse neostriatum: a quantitative radioautographic study of [3H]dopamine uptake.

Authors:  G Doucet; P Brundin; S Seth; Y Murata; R E Strecker; L C Triarhou; B Ghetti; A Björklund
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

8.  Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host neostriatum.

Authors:  J P Bolam; T F Freund; A Björklund; S B Dunnett; A D Smith
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

9.  Conditioning versus priming of dopaminergic grafts by amphetamine.

Authors:  L E Annett; P J Reading; D Tharumaratnam; D N Abrous; E M Torres; S B Dunnett
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

10.  Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.

Authors:  A Vinuela; P J Hallett; C Reske-Nielsen; M Patterson; T D Sotnikova; M G Caron; R R Gainetdinov; O Isacson
Journal:  Brain       Date:  2008-11-06       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.